FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:678-679 September 8, 1994 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Fanaroff, A. A.

To the Editor: We share the concern expressed by Dr. Tomasz and his colleagues (April 28 issue) in the report on multiple-antibiotic-resistant pathogenic bacteria,¹ particularly with regard to tuberculosis. However, we want to clarify an apparent misconception. The available data do not show that outbreaks of multidrug-resistant tuberculosis have occurred in 35 states, as noted in the report. Of the cases of culture-positive tuberculosis reported in the first quarter of 1991, cases of drug-resistant tuberculosis were identified in 36 states, and cases of multidrug-resistant tuberculosis, defined as tuberculosis resistant to isoniazid and rifampin (with or without resistance to other drugs), . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Goude, R., Amin, A. G., Chatterjee, D., Parish, T. (2009). The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53: 4138-4146 [Abstract] [Full Text]